167 related articles for article (PubMed ID: 37806747)
41. Potent α-amylase inhibitors and radical (DPPH and ABTS) scavengers based on benzofuran-2-yl(phenyl)methanone derivatives: Syntheses, in vitro, kinetics, and in silico studies.
Ali I; Rafique R; Khan KM; Chigurupati S; Ji X; Wadood A; Rehman AU; Salar U; Iqbal MS; Taha M; Perveen S; Ali B
Bioorg Chem; 2020 Nov; 104():104238. PubMed ID: 32911195
[TBL] [Abstract][Full Text] [Related]
42. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
43. Assessment of Anticholinergic and Antidiabetic Properties of Some Natural and Synthetic Molecules: An
Çomaklı V; Aygül İ; Sağlamtaş R; Kuzu M; Demirdağ R; Akincioğlu H; Adem Ş; Gülçin İ
Curr Comput Aided Drug Des; 2024; 20(5):441-451. PubMed ID: 37202895
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives.
Nawaz M; Taha M; Qureshi F; Ullah N; Selvaraj M; Shahzad S; Chigurupati S; Abubshait SA; Ahmad T; Chinnam S; Hisaindee S
J Biomol Struct Dyn; 2022; 40(21):10730-10740. PubMed ID: 34463216
[TBL] [Abstract][Full Text] [Related]
45. Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies.
Afolabi OB; Olasehinde OR; Olanipon DG; Mabayoje SO; Familua OM; Jaiyesimi KF; Agboola EK; Idowu TO; Obafemi OT; Olaoye OA; Oloyede OI
BMC Complement Med Ther; 2023 Jun; 23(1):203. PubMed ID: 37337198
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of Benzimidazole-Based Analogs as Anti Alzheimer's Disease Compounds and Their Molecular Docking Studies.
Adalat B; Rahim F; Taha M; Alshamrani FJ; Anouar EH; Uddin N; Shah SAA; Ali Z; Zakaria ZA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092223
[TBL] [Abstract][Full Text] [Related]
47. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
[TBL] [Abstract][Full Text] [Related]
48. Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
Hameed S; Khan KM; Salar U; Özil M; Baltaş N; Saleem F; Qureshi U; Taha M; Ul-Haq Z
Int J Biol Macromol; 2022 Nov; 221():1294-1312. PubMed ID: 36113601
[TBL] [Abstract][Full Text] [Related]
49. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
[TBL] [Abstract][Full Text] [Related]
50. Syntheses, in vitro, and in silico studies of rhodanine-based schiff bases as potential α-amylase inhibitors and radicals (DPPH and ABTS) scavengers.
Egu SA; Ali I; Khan KM; Chigurupati S; Qureshi U; Salar U; Taha M; Felemban SG; Venugopal V; Ul-Haq Z
Mol Divers; 2023 Apr; 27(2):767-791. PubMed ID: 35604512
[TBL] [Abstract][Full Text] [Related]
51. Metal-free synthesis of functionalized tacrine derivatives and their evaluation for acetyl/butyrylcholinesterase and α-glucosidase inhibition.
Shirisha T; Majhi S; Divakar K; Kashinath D
Org Biomol Chem; 2024 Jan; 22(4):790-804. PubMed ID: 38167698
[TBL] [Abstract][Full Text] [Related]
52. Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies.
Maqbool M; Solangi M; Khan KM; Özil M; Baltaş N; Salar U; Tariq SS; Haq ZU; Taha M
Arch Pharm (Weinheim); 2024 Jun; ():e2400325. PubMed ID: 38885529
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, structural characterizations, in vitro biological evaluation and computational investigations of pyrazole derivatives as potential antidiabetic and antioxidant agents.
Mortada S; Karrouchi K; Hamza EH; Oulmidi A; Bhat MA; Mamad H; Aalilou Y; Radi S; Ansar M; Masrar A; Faouzi MEA
Sci Rep; 2024 Jan; 14(1):1312. PubMed ID: 38225280
[TBL] [Abstract][Full Text] [Related]
54. In vitro antioxidant, anticholinesterases, anti-α-amylase, and anti-α-glucosidase effects of Algerian Salvia aegyptiaca and Salvia verbenaca.
Mamache W; Amira S; Ben Souici C; Laouer H; Benchikh F
J Food Biochem; 2020 Nov; 44(11):e13472. PubMed ID: 33000487
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4-oxadiazole derivatives.
Durmaz Ş; Evren AE; Sağlık BN; Yurttaş L; Tay NF
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200294. PubMed ID: 35972839
[TBL] [Abstract][Full Text] [Related]
56. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
[TBL] [Abstract][Full Text] [Related]
57. Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer's disease.
Türkan F; Taslimi P; Saltan FZ
J Biochem Mol Toxicol; 2019 Aug; 33(8):e22340. PubMed ID: 30974029
[TBL] [Abstract][Full Text] [Related]
58. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
[TBL] [Abstract][Full Text] [Related]
59. Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.
Mughal EU; Sadiq A; Ayub M; Naeem N; Javid A; Sumrra SH; Zafar MN; Khan BA; Malik FP; Ahmed I
J Biomol Struct Dyn; 2021 Oct; 39(16):6154-6167. PubMed ID: 32752941
[TBL] [Abstract][Full Text] [Related]
60. Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.
Babatunde O; Hameed S; Salar U; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Khan KM; Taha M; Perveen S
Mol Divers; 2022 Apr; 26(2):849-868. PubMed ID: 33650031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
